ContractConsulting Agreement • October 4th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledOctober 4th, 2024 Company IndustryPursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the U.S. Securities and Exchange Commission, certain portions of this exhibit have been omitted because it is both not material and the type of information that the company treats as private or confidential.
ContractConsulting Agreement • May 29th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledMay 29th, 2024 Company IndustryPursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the U.S. Securities and Exchange Commission, certain portions of this exhibit have been omitted because it is both not material and the type of information that the company treats as private or confidential.